FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

Dec 8, 2024 0 1.8k
Jan 28, 2025 0 390
Sep 21, 2024 0 360
Nov 21, 2024 0 300
May 7, 2024 0 246
News headlines uses cookies. By continuing to browse the site you are agreeing to our TERMS and to use of cookies.